Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (2)-epigallocatechin gallate

BioFactors

Volumn 35, Issue 3, 2009, Pages 279-294

  Dorchies, Olivier M ^a   Wagner, Stéphanie ^a   Buetler, Timo M ^a   Ruegg, Urs T ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

67LR; Glutathione; Green tea polyphenols; Myotube; Oxidative stress

Indexed keywords

67LR PROTEIN; EPIGALLOCATECHIN GALLATE; GLUTATHIONE; HYDROGEN PEROXIDE; POLYPHENOL DERIVATIVE; PROTEIN; UNCLASSIFIED DRUG; CATECHIN; DRUG DERIVATIVE; FLAVONOID; LAMININ RECEPTOR; PHENOL DERIVATIVE; POLYPHENOLS; PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATIONAL STUDY; FLUOROMETRY; MEMBRANE STABILIZATION; MOUSE; MUSCLE CELL; NEWBORN; NONHUMAN; ONLINE ANALYSIS; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT; OXIDATIVE STRESS; SKELETAL MUSCLE;

ANIMALS; ANIMALS, NEWBORN; CATECHIN; CELL SURVIVAL; CELLS, CULTURED; FLAVONOIDS; GLUTATHIONE; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, MUTANT STRAINS; MUSCLE CELLS; MUSCLE, SKELETAL; OXIDATIVE STRESS; PHENOLS; PROTEASE INHIBITORS; RECEPTORS, LAMININ; TEA;

EID: 69149093028     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.34     Document Type: Article

References (93)

1. Chakkalakal, J. V., Thompson, J., Parks, R. J., and Jasmin, B. J. (2005) Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies. FASEB J 19, 880-891.
2. Tidball, J., and Wehling-Henricks, M. (2004) Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events. Pediatr. Res 56, 831-841.
3. Wagner, K. R., Lechtzin, N., and Judge, D. P. (2007) Current treatment of adult Duchenne muscular dystrophy. Biochim. Biophys. Acta 1772, 229-237.
4. Muntoni, F., Fisher, I., Morgan, J. E., and Abraham, D. (2002) Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul. Disord 12 (Suppl 1), S162-S165.
5. Petrof, B. J. (1998) The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol. Cel. Biochem 179, 111-123.
6. Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., and Sweeney, H. L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710-3714.
7. Ruegg, U. T. and Gillis, J.-M. (1999) Calcium homeostasis in dystrophic muscle. Trends Pharmacol. Sci 20, 351-352.
8. Ruegg, U. T., Nicolas-Metral, V., Challet, C., Bernard-Helary, K., Dorchies, O. M., Wagner, S., and Buetler, T. M. (2002) Pharmacological control of cellular calcium handling in dystrophic skeletal muscle. Neuromuscul. Disord 12, S155-S161.
9. Boittin, F., Petermann, O., Hirn, C., Mittaud, P., Dorchies, O. M., Roulet, E., and Ruegg, U. T. (2006) Ca2+-independent phospholipase A2 enhances store-operated Ca2+ entry in dystrophic skeletal muscle fibers. J. Cell. Sci 119, 3733-3742.
10. Whitehead, N. P., Yeung, E. W., and Allen, D. G. (2006) Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin. Exp. Pharmacol. Physiol 33, 657-662.
11. Rando, T. A., Disatnik, M.-H., Yu, Y., and Franco, A. (1998) Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromusc. Disord 8, 14-21.
12. Moylan, J. S. and Reid, M. B. (2007) Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 35, 411-429.
13. Tidball, J. G. and Wehling-Henricks, M. (2007) The role of free radicals in the pathophysiology of muscular dystrophy. J. Appl. Physiol 102, 1677-1686.
14. Dudley, R. W. R., Khairallah, M., Mohammed, S., Lands, L., Des Rosiers, C., and Petrof, B. J. (2006) Dynamic responses of the glutathione system to acute oxidative stress in dystrophic mouse (mdx) muscles. Am. J. Physiol. Regul. Integr. Comp. Physiol 291, R704-R710.
15. Haycock, J. W., MacNeil, S., Jones, P., Harris, J. B., and Mantle, D. (1996) Oxidative damage to muscle protein in Duchenne muscular dystrophy. Neuroreport 8, 357-361.
16. Murphy, M. E. and Kehrer, J. P. (1986) Free radicals: a potential pathogenic mechanism in inherited muscular dystrophy. Life Sci 39, 2271-2278.
17. Nakae, Y., Stoward, P. J., Kashiyama, T., Shono, M., Akagi, A., Matsuzaki, T., and Nonaka, I. (2004) Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice. J. Mol. Histol 35, 489-499.
18. Rodriguez, C. and Tranopolsky, M. A. (2003) Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic. Biol. Med 34, 1217-1220.
19. Morré, D. J., Bridge, A., Wu, L. Y., and Morré, D. M. (2000) Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem. Pharmacol 60, 937-946.
20. Spurney, C. F., Knoblach, S., Pistilli, E. E., Nagaraju, K., Martin, G. R., and Hoffman, E. P. (2008) Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromusc. Disord 18, 371-381.
21. Colston, J. T., de la Rosa, S. D., Strader, J. R., Anderson, M. A., and Freeman, G. L. (2005) H2O2 activates Nox4 through PLA2-dependent arachidonic acid production in adult cardiac fibroblasts. FEBS Lett 579, 2533-2540.
22. Lindahl, M., Backman, E., Henriksson, K. G., Gorospe, J. R., and Hoffman, E. P. (1995) Phospholipase A2 activity in dystrophinopathies. Neuromuscul. Disord 5, 193-199.
23. Disatnik, M. H., Dhawan, J., Yu, Y., Beal, M. F., Whirl, M. M., Franco A. A., and Rando, T. A. (1998) Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state, J. Neurol. Sci 161, 77-84.
24. Crespy V. and Williamson, G. (2004) A review of the health effects of green tea catechins in in vivo animal models. J. Nutr 134, 3431S-3440S.
25. Nakachi, K., Eguchi, H., and Imai, K. (2003) Can teatime increase one's lifetime? Ageing Res. Rev 2, 1-10.
26. Brown, M. D. (1999) Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Altern. Med. Rev 4, 360-370.
27. Chen, Z. P., Schell, J. B., Ho C. T., and Chen, K. Y. (1998) Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett 129, 173-179.
28. Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S., and Mukhtar, H. (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 98, 10350-10355.
29. Higdon J. V. and Frei, B. (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food. Sci. Nutr 43, 89-143.
30. Wolfram, S. (2007) Effects of green tea and EGCg on cardiovascular and metabolic health. J. Am. Coll. Nutr 26, 373S-388S.
31. Aneja, R., Hake, P. W., Burroughs, T. J., Denenberg, A. G., Wong, H.R., and Zingarelli, B. (2004) Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol. Med 10, 55-62.
32. Hong, J. T., Ryu, S. R., Kim, H. J., Lee, J. K., Lee, S. H., Kim, D. B., Yun, Y. P., Ryu, J. H., Lee, B. M., and Kim, P. Y. (2000) Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury. Brain. Res. Bull 53, 743-749.
33. Suzuki, M., Tabuchi, M., Ikeda, M., Umegaki, K., and Tomita, T. (2004) Protective effects of green tea catechins on cerebral ischemic damage. Med. Sci. Monit 10, BR166-BR174.
34. Auvichayapat, P., Prapochanung, M., Tunkamnerdthai, O., Sripanidkulchai, B. O., Auvichayapat, N., Thinkhamrop, B., Kunhasura, S., Wongpratoom, S., Sinawat, S., and Hongprapas, P. (2007) Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial. Physiol. Behav 93, 486-491.
35. Boschmann, M. and Thielecke, F. (2007) The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J. Am. Coll. Nutr 26, 389S-395S.
36. Donà, M., Dell'Aica, I., Calabrese, F., Benelli, R., Morini, M., Albini, A., and Garbisa, S. (2003) Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol 170, 4335-4341.
37. Yumei, F., Zhou, Y., Zheng, S., and Chen, A. (2006) The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells. Lab. Invest 86, 697-709.
38. Zhong, Z., Froh, M., Lehnert, M., Schoonhoven, R., Yang, L., Lind, H., Lemasters, J. J., and Thurman, R. G. (2003) Polyphenols from Camellia sinensis attenuate experimental cholestasis-induced liver fibrosis in rats. Am. J. Physiol. Gastrointest. Liver Physiol 285, G1004-G1013.
39. Kondo, K., Kurihara, M., Miyata, N., Suzuki, T., and Toyoda, M. (1999) Scavenging mechanisms of (-)-epigallocatechin gallate and (-)-epicatechin gallate on peroxyl radicals and formation of superoxide during the inhibitory action. Free Radic. Biol. Med 27, 855-863.
40. Nakagawa, T. and Yokozawa, T. (2002) Direct scavenging of nitric oxide and superoxide by green tea. Food Chem. Toxicol 40, 1745-1750.
41. Bode, A. M. and Dong, Z. (2003) Signal transduction pathways: targets for green and black tea polyphenols. J. Biochem. Mol. Biol 36, 66-77.
42. Sachinidis, A., Skach, R. A., Seul, C., Ko, Y. O. N., Hescheler, J., Ahn, H.-Y., and Fingerle, J. (2002) Inhibition of the PDGF-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEB J 16, 893-895.
43. Sartippour, M. R., Heber, D., Zhang, L., Beatty, P., Elashoff, D., Elashoff, R., Go, V. L., and Brooks, M. N. (2002) Inhibition of fibroblast growth factors by green tea. Int. J. Oncol 21, 487-491.
44. Suganuma, M., Sueoka, E., Sueoka, N., Okabe, S., and Fujiki, H. (2000) Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-αlpha expression. Biofactors 13, 67-72.
45. Fujimura, Y., Umeda, D., Yamada, K., and Tachibana, H. (2008) The impact of the 67 kDa laminin receptor on both cell-surface binding and anti-allergic action of tea catechins. Arch. Biochem. Biophys 476, 133-138.
46. Tachibana, H., Koga, K., Fujimura, Y., and Yamada, K. (2004) A receptor for green tea polyphenol EGCg. Nat. Struct. Mol. Biol 11, 380-381.
47. Fujimura, Y., Umeda, D., Yano, S., Maeda-Yamamoto, M., Yamada, K., and Tachibana, H. (2007) The 67kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCg. Biochem. Biophys. Res. Commun 364, 79-85.
48. Buetler, T. M., Renard, M., Offord, E. A., Schneider, H., and Ruegg, U. T. (2002) Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am. J. Clin. Nutr 75, 749-753.
49. Dorchies, O. M., Wagner, S., Vuadens, O., Waldhauser, K., Buetler, T. M., Kucera P., and Ruegg, U. T. (2006) Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am. J. Physiol. Cell Physiol 290, C616-C625.
50. Nakae, Y., Hirasaka, K., Goto, J., Nikawa, T., Shono, M., Yoshida, M., and Stoward, P. J. (2008) Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study. Histochem. Cell Biol 129, 489-501.
51. Bulfield, G., Siller, W. G., Wight, P. A., and Moore, K. J. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81, 1189-1192. (Pubitemid 14171480)
52. De la Porte, S., Morin S., and Koenig, J. (1999) Characteristics of skeletal muscle in mdx mutant mice. Int. Rev. Cytol 191, 99-148.
53. Tanabe, Y., Esaki, K., and Nomura, T. (1986) Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (Berl.) 69, 91-95.
54. Im, W. B., Phelps, S. F., Copen, E. H., Adams, E. G., Slightom, J. L., and Chamberlain, J. S. (1996) Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum. Mol. Genet 5, 1149-1153.
55. Ueda, Y., Walsh, E., Nakanishi, H., and Yoshida, K. (1994) A colorimetric assay method for the evaluation of neurotrophic activity in vitro. Neurosci. Lett 165, 203-207.
56. Metzinger, L., Passaquin, A. C., Warter, J. M., and Poindron, P. (1993) α-Methylprednisolone promotes skeletal myogenesis in dystrophindeficient and control mouse cultures. Neurosci. Lett 155, 171-174. (Pubitemid 23190291)
57. Nicolas-Metral, V., Raddatz, E., Kucera, P., and Ruegg, U. T. (2001) Mdx myotubes have normal excitability but show reduced contraction-relaxation dynamics. J. Muscle Res. Cell Motil 22, 69-75.
58. Han R. and Campbell, K. P. (2007) Dysferlin and muscle membrane repair. Curr. Opin. Cell Bio 19, 409-416.
59. Nelson, J., McFerran, N. V., Pivato, G., Chambers, E., Doherty, C., Steele, D., and Timson, D. J. (2008) The 67 kDa laminin receptor: structure, function and role in disease. Biosci. Rep 28, 33-48.
60. Castronovo, V., Claysmith, A. P., Barker, K. T., Cioce, V., Krutzsch, H. C., and Sobel, M. E. (1991) Biosynthesis of the 67 kDa high affinity laminin receptor. Biochem. Biophys. Res. Commun 177, 177-183.
61. Jung, C., Martins, A. S., Niggli, E., and Shirokova, N. (2008) Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. Cardiovasc. Res 77, 766-773.
62. Jackson, M. J., Pye, D., and Palomero, J. (2007) The production of reactive oxygen and nitrogen species by skeletal muscle. J. Appl. Physiol 102, 1664-1670.
63. Ji, L. L. (2007) Antioxidant signaling in skeletal muscle: a brief review. Exp. Gerontol 42, 582-593.
64. Callahan, L. A., She, Z. W., and Nosek, T. M. (2001) Superoxide, hydroxyl radical, and hydrogen peroxide effects on single-diaphragm fiber contractile apparatus. J. Appl. Physiol 90, 45-54.
65. Edwards, J. N., Macdonald, W. A., van der Poel, C., and Stephenson, D. G. (2007) O2 production at 37 degrees C plays a critical role in depressing tetanic force of isolated rat and mouse skeletal muscle. Am. J. Physiol. Cell Physiol 293, C650-C660.
66. Niess, A. M. and Simon, P. (2007) Response and adaptation of skeletal muscle to exercise - the role of reactive oxygen species. Front. Biosci 12, 4826-4838.
67. St-Pierre, J., Buckingham, J. A., Roebuck, S. J., and Brand, M. D. (2002) Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem 277, 44784-44790.
68. Hidalgo, C., Sanchez, G., Barrientos, G., and Aracena-Parks, P. (2006) A transverse tubule NADPH oxidase activity stimulates calcium release from isolated triads via ryanodine receptor type 1 S-glutathionylation. J. Biol. Chem 281, 26473-26482.
69. Spencer, M. J. and Tidball, J. G. (2001) Do immune cells promote the pathology of dystrophin-deficient myopathies?Neuromuscul. Disord 11, 556-564.
70. Xia, R., Webb, J. A., Gnall, L. L., Cutler, K., and Abramson, J. J. (2003) Skeletal muscle sarcoplasmic reticulum contains a NADH-dependent oxidase that generates superoxide. Am. J. Physiol. Cell Physiol 285, C215-C221.
71. Grounds, M. and Torrisi, J. (2004) Anti-TNFa (RemicadeVR ) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 18, 676-682.
72. Whitehead, N. P., Pham, C., Gervasio, O. L., and Allen, D. G. (2008) N-acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 586, 2003-2014.
73. Mickle, D. A. G., Li, R.-K., Weisel, R. D., Tumiati, L. C., and Wu, T-W. (1990) Water-soluble antioxidant specificity against free radical injury using cultured human ventricular myocytes and fibroblasts and saphenous vein endothelial cells. J. Mol. Cell. Cardiol 22, 1297-1304.
74. Melone, M. A. B., Peluso, G., Galderisi, U., Petillo, O., and Cotrufo, R. (2000) Increased expression of IGF-binding protein-5 in Duchenne Muscular Dystrophy (DMD) fibroblasts correlates with the fibroblastinduced downregulation of DMD myoblast growth: an in vitro analysis. J. Cell. Physiol 185, 143-153.
75. Quinn, L. S., Ong, L. D., and Roeder, R. A. (1990) Paracrine control of myoblast proliferation and differentiation by fibroblasts. Dev. Biol 140, 8-19.
76. Fadic, R., Mezzano, V., Alvarez, K., Cabrera, D., Holmgren, J., and Brandan, E. (2006) Increase in decorin and biglycan in Duchenne muscular dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease. J. Cell. Molec. Med 10, 758-769.
77. Zou, Y., Zhang, R. Z., Sabatelli, P., Chu, M. L., and Bonnemann, C. G. (2008) Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem. J. Neuropathol. Exp. Neurol 67, 144-154.
78. Salah, N., Miller, N. J., Paganga, G., Tijburg, L., Bolwell, G. P., and Rice-Evans, C. (1995) Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys 322, 339-346.
79. Sah, J. F., Balasubramanian, S., Eckert, R. L., and Rorke, E. A. (2004) Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway: evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem 279, 12755-12762.
80. Steffen, Y., Gruber, C., Schewe, T., and Sies, H. (2008) Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys 469, 209-219.
81. Steffen, Y., Schewe, T., and Sies, H. (2007) (-)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem. Biophys. Res. Commun 359, 828-833.
82. Akagawa, M., Shigemitsu, T., and Suyama, K. (2003) Production of hydrogen peroxide by polyphenols and polyphenol-rich beverages under quasi-physiological conditions. Biosci. Biotechnol. Biochem 67, 2632-2640.
83. Arakawa, H., Maeda, M., Okubo, S., and Shimamura, T. (2004) Role of hydrogen peroxide in bactericidal action of catechin, Biol. Pharm. Bull 27, 277-281.
84. Williams, S. N., Pickwell, G. V., and Quattrochi, L. C. (2003) A combination of tea (Camellia senensis) catechins is required for optimal inhibition of induced CYP1A expression by green tea extract. J. Agric. Food Chem 51, 6627-6634.
85. Hinek, A. (1994) Nature and the multiple functions of the 67-kD elastin-/laminin binding protein, Cell Adhes. Commun 2, 185-193.
86. Carlsen, H., Myhrstad, M. C. W., Thoresen, M., Moskaug, J. O., and Blomhoff, R. (2003) Berry intake increases the activity of the c-glutamylcysteine synthetase promoter in transgenic reporter Mice. J. Nutr 133, 2137-2140.
87. Moskaug, J. O., Carlsen, H., Myhrstad, M. C. W., and Blomhoff, R. (2005) Polyphenols and glutathione synthesis regulation. Am. J. Clin. Nutr 81, 277S-283S.
88. Clausse, N., van den Brûle, F., Delvenne, P., Jacobs, N., Franzen-Detrooz, E., Jackers P., and Castronovo, V. (1998) TNF-α and IFN-γ down-regulate the expression of the metastasis-associated bi-functional 37LRP/p40 gene and protein in transformed keratinocytes. Biochem. Biophys. Res. Commun 251, 564-569.
89. Umeda, D., Yano, S., Yamada, K., and Tachibana, H. (2008) Involvement of 67-kDa laminin receptor-mediated myosin phosphatase activation in antiproliferative effect of epigallocatechin-3-O-gallate at a physiological concentration on Caco-2 colon cancer cells. Biochem. Biophys. Res. Commun 371, 172-176.
90. Bubici, C., Papa, S., Dean, K., and Franzoso, G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25, 6731-6748.
91. Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J. H., Xue, X., and Okumura, K. (2005) Reactive oxygen species mediate crosstalk between NF-jB and JNK. Cell Death Differ 13, 730-737.
92. Kolodziejczyk, S. M., Walsh, G. S., Balazsi, K., Seale, P., Sandoz, J., Hierlihy, A. M. Rudnicki, M. A., Chamberlain, J. S., Miller, F. D., and Megeney, L. A. (2001) Activation of JNK1 contributes to dystrophic muscle pathogenesis, Curr. Biol 11, 1278-1282.
93. Messina, S., Altavilla, D., Aguennouz, M., Seminara, P., Minutoli, L., Monici, M. C., Bitto, A., Mazzeo, A., Marini, H., Squadrito, F., and Vita, G. (2006) Lipid peroxidation inhibition blunts nuclear factor-B activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am. J. Pathol 168, 918-926. (Pubitemid 43327744)